MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 59 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,747 | -83.0% | 8,130 | -82.0% | 0.00% | – |
| Q4 2022 | $33,806 | -36.2% | 45,074 | -27.2% | 0.00% | – |
| Q3 2022 | $53,000 | -1.9% | 61,888 | +28.1% | 0.00% | – |
| Q2 2022 | $54,000 | +157.1% | 48,301 | +158.4% | 0.00% | – |
| Q1 2022 | $21,000 | -27.6% | 18,694 | +2.2% | 0.00% | – |
| Q4 2021 | $29,000 | +222.2% | 18,294 | +378.1% | 0.00% | – |
| Q3 2021 | $9,000 | -75.0% | 3,826 | -66.5% | 0.00% | – |
| Q2 2021 | $36,000 | – | 11,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |